Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
847.00    -9.00 (-1.05%)
Bid:
836.00
Ask:
847.00
Spread: 11.00 (1.316%)
Market Cap: £798.98m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Director/PDMR Shareholding - Replacement

19 Aug 2025 11:08

RNS Number : 9183V
Polar Capital Holdings PLC
19 August 2025
 

19 August 2025

 

The following amendments have been made to the Director/PDMR Shareholding announcement released on 15 August 2025 at 9:42am under RNS No 5227V.

 

The prices have been amended.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Polar Capital Holdings plc ("Polar Capital" or the "Company")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

 

The Company was notified on 13 August 2025 that Ms. Rachel Stynes purchased 1,801 ordinary shares of 2.5p each ("Ordinary Shares") following an automatic dividend reinvestment for her personal holding at an aggregated price of 486.55p per share. Following this transaction Ms. Stynes is interested in a total of 32,033 Ordinary Shares representing 0.03% of the Company's issued share capital.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Rachel Stynes

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of Human Resources

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Polar Capital Holdings plc

b)

 

LEI

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

Identification code

GB00B1GCLT25

b)

 

Nature of the transaction

 

Acquisition following dividend reinvestment

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

487.59 pence per share

980

485.50 pence per share

821

d)

 

Aggregated information

as in 4 c) above

- Aggregated volume

1801

- Price

486.55 pence per share

 

e)

 

Date of the transaction

 

13/08/2025

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Polar Capital +44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

Samir Ayub (CFO)

 

Deutsche Numis - Nomad and Joint Broker +44 (0)20 7260 1000

Giles Rolls (QE)

Charles Farquhar

 

Peel Hunt LLP - Joint Broker +44 (0)20 3597 8680

Andrew Buchanan

Sam Milford

 

Camarco +44 (0)20 7757 4995

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEPNFELSEFA
Date   Source Headline
21st Jun 201111:13 amRNSHolding(s) in Company
21st Jun 201111:10 amRNSDirector/PDMR Shareholding
14th Jun 20117:00 amRNSPreliminary Results
23rd May 201111:00 amRNSNotice of Preliminary Results
19th Apr 20117:00 amRNSAUM Update
11th Apr 20114:19 pmRNSHolding(s) in Company
3rd Feb 20113:11 pmRNSDirector/PDMR Shareholding
31st Jan 201110:00 amRNSDirector/PDMR Shareholding
14th Jan 20117:00 amRNSAUM Update
7th Jan 20117:00 amRNSClosure of the Polar Capital Discovery Fund
20th Dec 20101:35 pmRNSDirector/PDMR Shareholding
10th Dec 20107:00 amRNSInterim Results
26th Nov 20104:06 pmRNSNotice of Interim Results
15th Oct 20107:00 amRNSAUM Update
30th Sep 20109:08 amRNSTotal Voting Rights
23rd Sep 20104:45 pmRNSHolding(s) in Company
23rd Sep 20104:45 pmRNSDirector/PDMR Shareholding
21st Sep 201012:35 pmRNSCompletion of Acquisition of HIM Capital
15th Sep 20107:00 amRNSAcquisition of HIM Capital
9th Sep 20103:33 pmRNSAGM Statement
16th Jul 20107:00 amRNSAUM Update
9th Jul 20108:22 amRNSAnnual Financial Report
8th Jul 20101:00 pmRNSAnnual Financial Report
29th Jun 20102:53 pmRNSDirectorship
23rd Jun 20107:00 amRNSPreliminary Results for year ended 31 March 2010
17th Jun 20109:00 amRNSNotice of Preliminary Results
19th Apr 20107:00 amRNSIntention to Launch a Global Healthcare Trust
15th Apr 20107:00 amRNSAUM Update
1st Apr 20109:42 amRNSTotal Voting Rights
30th Mar 20103:58 pmRNSDirector/PDMR Shareholding
5th Mar 20108:05 amRNSHolding(s) in Company
5th Mar 20108:04 amRNSHolding(s) in Company
1st Mar 20108:01 amRNSTotal Voting Rights
25th Feb 201012:04 pmRNSAdditional Listing & Dividend Declaration
19th Feb 201010:58 amRNSHolding(s) in Company
16th Feb 20102:20 pmRNSAdditional Listing
11th Feb 20109:22 amRNSHolding(s) in Company
10th Feb 20105:16 pmRNSHolding(s) in Company
22nd Jan 20102:50 pmRNSDirector/PDMR Shareholding
14th Jan 20104:04 pmRNSHolding(s) in Company
12th Jan 20107:00 amRNSAUM Update
31st Dec 20097:00 amRNSTotal Voting Rights
22nd Dec 20098:00 amRNSAdditional Listing
16th Dec 20098:00 amRNSAdditional Listing
11th Dec 20097:00 amRNSInterim Results
3rd Dec 200912:47 pmRNSNotice of Interim Results
3rd Nov 20097:00 amRNSDirectorate Change
15th Oct 20097:00 amRNSAUM Update
10th Sep 20094:04 pmRNSResult of AGM
5th Aug 20099:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.